Silver sulfadiazine contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Silver sulfadiazine}} {{CMG}}; {{AE}} {{chetan}} ==Contraindications== Silver Sulfadiazine Cream is contraindicated in patients who are hypersensitive to silver ..." |
|||
| Line 6: | Line 6: | ||
Silver Sulfadiazine Cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. | Silver Sulfadiazine Cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. | ||
Because sulfonamide therapy is known to increase the possibility of kernicterus, Silver Sulfadiazine Cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SILVER SULFADIAZENE (SILVER SULFADIAZINE) CREAM [WATSON LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=828d5862-c8ac-40a8-b161-9734dd0aec29 | publisher = | date = | accessdate = }}</ref> | Because sulfonamide therapy is known to increase the possibility of [[kernicterus]], Silver Sulfadiazine Cream should not be used on pregnant women approaching or at term, on [[premature infants]], or on newborn infants during the first 2 months of life.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SILVER SULFADIAZENE (SILVER SULFADIAZINE) CREAM [WATSON LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=828d5862-c8ac-40a8-b161-9734dd0aec29 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 05:38, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
Silver Sulfadiazine Cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. Because sulfonamide therapy is known to increase the possibility of kernicterus, Silver Sulfadiazine Cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.[1]
References
Adapted from the FDA Package Insert.